Polyether compounds not only have excellent efficacy against a variety of key infectious disease targets (including protozoa, bacteria and viruses), but also show selectivity and high performance against multiple MDR pathogens. At present, although PEs have been widely used in the potential control of drug-resistant bacteria and parasitic infections, the relevant medical chemistry and pharmacokinetic research data is very limited. Creative Biolabs helps customers produce high-quality antibodies by providing polyether hapten design and synthesis services. Our work can help the detection and research of polyether compounds. Learn more, https://small-molecule-antibody.creative-biolabs.com/polyethers-antibiotics-pes-hapten-design-and-synthesis.htm.